CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 980542593
- Phone
- (877) 237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-24 | DRACHMAN JONATHAN G President and CEO | Purchase | +100,000 | $6.11 | $611K | 2,348,686 |
| 2021-08-03 | Walkey Carl Senior Vice President | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-08-03 | Vance Holly General Counsel | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-08-03 | Patel Priti Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-08-03 | Ho Robert Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2021-08-03 | DRACHMAN JONATHAN G President and CEO | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2021-06-16 | Walkey Carl Senior Vice President | Sale | −600 | $10.19 | $6K | 1,352,489 |
| 2021-06-09 | Walkey Carl Senior Vice President | Sale | −650 | $10.82 | $7K | 1,353,089 |
| 2021-06-08 | Walkey Carl Senior Vice President | Sale | −600 | $11.00 | $7K | 1,353,739 |
| 2021-06-04 | Walkey Carl Senior Vice President | Sale | −600 | $10.00 | $6K | 1,354,339 |
| 2021-06-04 | DRACHMAN JONATHAN G President and CEO | Purchase | +10,000 | $9.61 | $96K | 2,248,686 |
| 2021-06-03 | DRACHMAN JONATHAN G President and CEO | Purchase | +40,000 | $9.48 | $379K | 2,238,686 |
| 2021-05-26 | Walkey Carl Senior Vice President | Sale | −600 | $10.00 | $6K | 1,354,939 |
| 2021-05-19 | Walkey Carl Senior Vice President | Sale | −600 | $10.63 | $6K | 1,355,539 |
| 2021-05-11 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-05-11 | Williams Lewis T Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-05-11 | SIMPSON TODD E Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-05-11 | Noonberg Sarah B. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 8 of 8 · 158 trades